Clinical Trial Update: The Effect Of Dose Titration And Dose Tapering On The Tolerability Of DVS SR In Women With Vasomotor Symptoms [Phase 3]

View source ↗

Summary

This Phase 3 trial assessed how dose titration and tapering influence the tolerability of DVS SR in women with menopausal vasomotor symptoms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause

Drugs mentioned

• DVS SR

Snippet

Sponsor: Pfizer | Conditions: Vasomotor Symptoms | Phase 3 | Status: COMPLETED | Results posted: 2011-10-12